These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 11482017)

  • 21. Prevention of venous thromboembolism in the rehabilitation phase after spinal cord injury: prophylaxis with low-dose heparin or enoxaparin.
    Spinal Cord Injury Thromboprophylaxis Investigators
    J Trauma; 2003 Jun; 54(6):1111-5. PubMed ID: 12813331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patient compliance with outpatient prophylaxis: an observational study.
    Colwell CW; Pulido P; Hardwick ME; Morris BA
    Orthopedics; 2005 Feb; 28(2):143-7. PubMed ID: 15751368
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Perspectives for application of heparin derivates in the treatment of patients with pulmonary cancer].
    Sukhoversha OA
    Klin Khir; 2006 Feb; (2):41-7. PubMed ID: 16826816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of obesity on outcomes after fondaparinux, enoxaparin, or heparin treatment for acute venous thromboembolism in the Matisse trials.
    Davidson BL; Büller HR; Decousus H; Gallus A; Gent M; Piovella F; Prins MH; Raskob GE; Segers AE; Lensing AW;
    J Thromb Haemost; 2007 Jun; 5(6):1191-4. PubMed ID: 17403087
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clexane in prevention of acute venous thrombosis and pulmonary thromboembolism].
    Kirienko AI; Zolotukhin IA
    Ter Arkh; 1998; 70(11):78-80. PubMed ID: 9949471
    [No Abstract]   [Full Text] [Related]  

  • 26. [Perioperative Bridging with Enoxaparin. Results of the Prospective BRAVE Registry with 779 Patients].
    Omran H; Hammerstingl C; Paar WD;
    Med Klin (Munich); 2007 Oct; 102(10):809-15. PubMed ID: 17928964
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The prevention of postoperative deep venous thrombosis in orthopedic surgery].
    Rybachuk OI; Besiedyns'kyĭ SM; Huliaiev DV
    Lik Sprava; 1999 Sep; (6):95-9. PubMed ID: 10626456
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Maximizing chemoprophylaxis against venous thromboembolism in abdominoplasty patients with the use of preoperative heparin administration.
    Campbell W; Pierson J; Cohen-Shohet R; Mast BA
    Ann Plast Surg; 2014; 72(6):S94-6. PubMed ID: 24691325
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Anticoagulation with low molecular weight heparins within the framework of cardioversion for atrial fibrillation].
    Tebbe U
    Dtsch Med Wochenschr; 2007 Sep; 132(39):2033-6. PubMed ID: 17882745
    [No Abstract]   [Full Text] [Related]  

  • 30. A comparison of recombinant hirudin with a low-molecular-weight heparin to prevent thromboembolic complications after total hip replacement.
    Eriksson BI; Wille-Jørgensen P; Kälebo P; Mouret P; Rosencher N; Bösch P; Baur M; Ekman S; Bach D; Lindbratt S; Close P
    N Engl J Med; 1997 Nov; 337(19):1329-35. PubMed ID: 9358126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of 'winners' to enoxaparin in the prevention of postoperative venous thromboembolism in digestive surgery.
    Reiertsen O; Mowinckel P; Bjerkeseth O; Løvig T; Thorsen G; Gerner T; Løtveit T; Larsen S
    Scand J Gastroenterol; 1996 Jun; 31(6):616-21. PubMed ID: 8789903
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Summary and perspectives. Rivaroxaban].
    Albaladejo P
    Ann Fr Anesth Reanim; 2008 Dec; 27 Suppl 3():S28-31. PubMed ID: 19185785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bariatric surgery for morbid obesity.
    Chen R; Takahashi T; Kanda T
    N Engl J Med; 2007 Sep; 357(11):1159; author reply 1159-60. PubMed ID: 17874476
    [No Abstract]   [Full Text] [Related]  

  • 34. [Comparative efficacy of low molecular heparin (fraxiparine), non-fractionized heparin and anti-aggregate therapy in the prophylaxis complex for thromboembolic complications after surgical interventions performed for oncological disease].
    Malanov VA; Nechvidova EA; Fomina SA
    Klin Khir; 2000 May; (5):35-8. PubMed ID: 11288242
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A simple venous thromboembolism prophylaxis protocol for patients undergoing bariatric surgery.
    Frezza EE; Wachtel MS
    Obesity (Silver Spring); 2006 Nov; 14(11):1961-5. PubMed ID: 17135612
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enoxaparin effect depends on body-weight and current doses may be inadequate in obese patients.
    Frederiksen SG; Hedenbro JL; Norgren L
    Br J Surg; 2003 May; 90(5):547-8. PubMed ID: 12734859
    [No Abstract]   [Full Text] [Related]  

  • 37. [Prevention of thromboembolic accidents in digestive surgery].
    Farah A; Herbinet B
    Ann Chir; 1972 Dec; 26(25):1353-4. PubMed ID: 4648418
    [No Abstract]   [Full Text] [Related]  

  • 38. Half-dose enoxaparin vs. full-dose enoxaparin for postoperative bridging therapy in patients after cardiac surgery: which dose regimen should be preferred?
    Weiss A; Brose S; Ploetze K; Matschke K
    Clin Hemorheol Microcirc; 2013 Jan; 54(3):249-58. PubMed ID: 23648452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Enoxaparin (clexane) in the prevention of thromboembolism after total hip replacement].
    Babiak I; Jabłoński T; Serafin J
    Chir Narzadow Ruchu Ortop Pol; 1993; 58(2):14-7. PubMed ID: 7671674
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is once- or twice-a-day enoxaparin as effective as unfractionated heparin for the treatment of venous thromboembolism (VTE)?
    Marsland T; Newton W
    J Fam Pract; 2001 May; 50(5):396. PubMed ID: 11350700
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.